Danny is a founder, co-founder, or founding investor in med tech companies including now commercial Mainstay Medical, Respicardia (acquired), CoTherix (acquired), and Neuronetics (STIM). He serves on the Boards of Nortech Systems (NSYS) and multiple private companies, and leads the Innovation Fellows Program at the U. of Minnesota’s Institute for Engineering in Medicine. Danny was previously a member of the faculty in the Division of Emergency Medicine at Harvard Medical School, and a venture capital investor. He earned an MD from the U. of Michigan, and MBA from Harvard Business School.
